CIK 0000072444 · Accelerated filer<br>Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 591212264
- Phone
- (650) 550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-13 | Wheadon David E. Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2025-06-13 | Finney Michael J. Director | Grant or award | +16,000 | 702,840 | ||
| 2025-06-13 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2025-05-19 | Grasman Jeroen Nicolaas Chief Financial Officer | Grant or award | +350,000 | 350,000 | ||
| 2025-05-19 | Grasman Jeroen Nicolaas Chief Financial Officer | Grant or award · Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2025-05-19 | Lo Steven President, Chief Exec Officer | Purchase | +100,000 | $0.49 | $49K | 100,000 |
| 2025-03-28 | Cummings James F. Chief Medical Officer | Shares withheld for taxes | −3,292 | $0.42 | $1K | 745,757 |
| 2025-03-28 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −3,913 | $0.42 | $2K | 740,490 |
| 2025-03-24 | Lo Steven President, Chief Exec Officer | Grant or award | +1,405,000 | 1,632,638 | ||
| 2025-03-24 | Lo Steven President, Chief Exec Officer | Grant or award · Stock Option (right to buy) | +2,108,000 | 2,108,000 | ||
| 2025-03-24 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +406,000 | 744,403 | ||
| 2025-03-24 | Tucker Sean SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +610,000 | 610,000 | ||
| 2025-03-24 | Lee Phillip E Chief Financial Officer | Grant or award | +406,000 | 631,619 | ||
| 2025-03-24 | Lee Phillip E Chief Financial Officer | Grant or award · Stock Option (right to buy) | +610,000 | 610,000 | ||
| 2025-03-24 | Cummings James F. Chief Medical Officer | Grant or award | +406,000 | 749,049 | ||
| 2025-03-24 | Cummings James F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +610,000 | 610,000 | ||
| 2025-03-24 | Cummings James F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-03-24 | Berg Edward B SVP, General Counsel | Grant or award | +406,000 | 694,123 | ||
| 2025-03-24 | Berg Edward B SVP, General Counsel | Grant or award · Stock Option (right to buy) | +610,000 | 610,000 | ||
| 2025-03-24 | Berg Edward B SVP, General Counsel | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 4 of 10 · 198 trades